fda’s perspective on physiologically based pharmacokinetic analyses for biopharmaceutic applications
Published 3 years ago • 222 plays • Length 21:52Download video MP4
Download video MP3
Similar videos
-
0:54
gastroplus® workshop: physiologically based pharmacokinetic modeling for fih predictions
-
59:39
physiologically based pharmacokinetic modelling for first‑in‑human predictions
-
1:26:54
applications experiences of pbpk modeling to support regulatory interactions
-
1:23:40
applications of gastroplus pbpk modeling at the fda office of generic drugs
-
24:42
clinical track: a physiologically pharmacokinetic model based approach for predicting dose of...
-
5:13
simulations plus - company overview
-
1:03:59
dddplus™ v6 webinar: in vitro dissolution... reimagined
-
1:19:00
reimagine the in vitro dissolution experiment with dddplus 5.0...
-
1:22:00
gastroplus™ 9.5 release webinar: something for everyone
-
1:16:28
physiology based pharmacokinetic modeling in generic drug development and regulatory decisions
-
58:59
pbpk modeling of pulmonary drug absorption: challenges & perspective
-
1:23:25
application of pbpk modeling in pediatric drug development (gastroplus®)
-
28:54
discovery preclinical track: high-throughput physiologically based pharmacokinetic modeling and...
-
1:05:05
utilization of pbbm/pbpk models for building a safe space and regulatory applications in support of
-
57:41
application of pbpk modeling & simulation to support dose selection in special populations
-
1:11
simulations plus 2021
-
58:18
unlocking the power of pbpk modeling: pbpk for first-in-human and beyond
-
1:05:07
first in human (fih) pbpk predictions
-
28:57
pre clinical track: ophthalmic clinical pharmacokinetic/pharmacodynamic prediction using pbpk model
-
6:38
the use of pbpk modeling in drug discovery
-
3:37
simulations plus company overview video.